Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis
NCT: NCT06921551 · COMPLETED
Brief Summary
The goal of this study is to explore the potential clinical benefits of the ABLE Exoskeleton as part of a rehabilitation program in people with multiple sclerosis. The main question it aims to answer is: Can a rehabiliation program with the ABLE Exoskeleton help to mantain the physical and psychosocial health of people with multiple sclerosis? Participants will: * Have a gait training session of 60 min with the exoskeleton once a week for 12 months at the clinic * Have an evaluation (tests and questionnaires) every 3 months at the clinic
Frequently Asked Questions
What is Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis?
Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis is a clinical trial registered under NCT06921551. Current status: COMPLETED.
What is the status of NCT06921551?
The current status of NCT06921551 (Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis) is: COMPLETED.
When did Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis start?
Exploratory Pilot Study on the Prolonged Use of the ABLE Exoskeleton in Multiple Sclerosis started on 2025-04-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.